HCA Healthcare (HCA)
(Delayed Data from NYSE)
$305.11 USD
+8.11 (2.73%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $302.98 -2.13 (-0.70%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
HCA 305.11 +8.11(2.73%)
Will HCA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HCA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HCA
Will Acute Care Unit Aid Universal Health's (UHS) Q1 Earnings?
HCA Healthcare (HCA) Earnings Expected to Grow: Should You Buy?
HCA: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
Other News for HCA
Interesting HCA Put And Call Options For December 20th
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Early notable gainers among liquid option names on April 19th
Hospital survey weakened 'dramatically' in March, says TD Cowen
HCA Healthcare Inc. stock underperforms Wednesday when compared to competitors